<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05048316</url>
  </required_header>
  <id_info>
    <org_study_id>MCC-21053</org_study_id>
    <nct_id>NCT05048316</nct_id>
  </id_info>
  <brief_title>Study to Develop a Group-Based E-Health Intervention for YA Cancer Survivors</brief_title>
  <official_title>Pilot Study to Develop a Group-Based E-Health Intervention for Young Adult Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>H. Lee Moffitt Cancer Center and Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>H. Lee Moffitt Cancer Center and Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators will test an evidence-based behavioral intervention that is responsive to Young&#xD;
      Adults (YA's) expressed needs and priorities&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2021</start_date>
  <completion_date type="Anticipated">October 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Satisfaction assessed by study-specific survey during the intervention - Acceptability</measure>
    <time_frame>During intervention</time_frame>
    <description>The intervention will be deemed acceptable if, on average, participants report satisfaction with the weekly sessions as ≥2 on a 0-4 scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Satisfaction assessed by study-specific survey after the intervention - Acceptability</measure>
    <time_frame>Immediately after the intervention</time_frame>
    <description>The intervention will be deemed acceptable if, on average, participants report satisfaction with the overall program and intent to continue using the intervention skills as ≥2 on a 0-4 scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Session attendance after the intervention - Acceptability</measure>
    <time_frame>Immediately after the intervention</time_frame>
    <description>Videoconference delivery will be acceptable if average group attendance is ≥6/10 sessions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life before intervention</measure>
    <time_frame>Baseline</time_frame>
    <description>Participants will complete the 27-item Functional Assessment of Cancer Therapy - General</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life at after intervention</measure>
    <time_frame>Immediately after intervention</time_frame>
    <description>Participants will complete the 27-item Functional Assessment of Cancer Therapy - General</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Symptom burden before intervention</measure>
    <time_frame>Baseline</time_frame>
    <description>Participants will complete the 22-item Impact of Event Scale-Revised</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Symptom burden after intervention</measure>
    <time_frame>Immediately after intervention</time_frame>
    <description>Participants will complete the 22-item Impact of Event Scale-Revised</description>
  </other_outcome>
  <other_outcome>
    <measure>Cancer-related distress before intervention</measure>
    <time_frame>Baseline</time_frame>
    <description>Participants will complete the 22-item Impact of Event Scale-Revised</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in cancer-related distress after intervention</measure>
    <time_frame>Immediately after intervention</time_frame>
    <description>Participants will complete the 22-item Impact of Event Scale-Revised</description>
  </other_outcome>
  <other_outcome>
    <measure>Stress management skills self-efficacy before intervention</measure>
    <time_frame>Baseline</time_frame>
    <description>Participants will complete subscales from the Measure of Current Status</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in stress management skills self-efficacy after intervention</measure>
    <time_frame>Immediately after intervention</time_frame>
    <description>Participants will complete subscales from the Measure of Current Status</description>
  </other_outcome>
  <other_outcome>
    <measure>Coping before intervention</measure>
    <time_frame>Baseline</time_frame>
    <description>Participants will complete the Brief-COPE</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in coping after intervention</measure>
    <time_frame>Immediately after intervention</time_frame>
    <description>Participants will complete the Brief-COPE</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Cancer Survivor</condition>
  <condition>Young Adult</condition>
  <arm_group>
    <arm_group_label>eHealth</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Weekly video conference groups led by a trained facilitator</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive-Behavioral Stress Management and Health Education</intervention_name>
    <description>Participants will attend group sessions with a trained facilitator held over videoconference. Sessions will each last 2 hours and will be held once weekly for 10 weeks. Sessions will include Cognitive-Behavioral Stress Management and health education content.</description>
    <arm_group_label>eHealth</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-39 years old&#xD;
&#xD;
          -  Diagnosed with cancer between 18-39 years old&#xD;
&#xD;
          -  Cancer diagnosis was non-metastatic&#xD;
&#xD;
          -  Completed cancer treatment between 1 month and 5 years prior to enrollment, with the&#xD;
             exception of ongoing hormone therapy&#xD;
&#xD;
          -  No documented or observable psychiatric or neurological disorders that could interfere&#xD;
             with participation (e.g., active psychosis, active substance abuse), as identified by&#xD;
             the referring medical team, chart review, or screening&#xD;
&#xD;
          -  Able to speak and read English&#xD;
&#xD;
          -  Able to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Metastatic disease&#xD;
&#xD;
          -  Continued cancer treatment&#xD;
&#xD;
          -  Psychiatric or neurological disorders that could interfere with study participation&#xD;
&#xD;
          -  Vulnerable populations will not be included&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura Oswald, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moffitt Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jocelyn Del Rio</last_name>
    <phone>1 813-745-2853</phone>
    <email>Jocelyn.DelRio@moffitt.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yvelise Rodriguez</last_name>
    <phone>1 813-745-1814</phone>
    <email>Yvelise.Rodriguez@moffitt.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Moffitt Cancer Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jocelyn Del Rio</last_name>
      <phone>813-745-2853</phone>
      <email>Jocelyn.DelRio@moffitt.org</email>
    </contact>
    <contact_backup>
      <last_name>Yvelise Rodriguez</last_name>
      <phone>1 813-745-1814</phone>
      <email>Yvelise.Rodriguez@moffitt.org</email>
    </contact_backup>
    <investigator>
      <last_name>Laura Oswald, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Heather Jim, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Damon Reed, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://moffitt.org/clinical-trials-research/clinical-trials/</url>
    <description>Moffitt Clinical Trial Search</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 31, 2021</study_first_submitted>
  <study_first_submitted_qc>September 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2021</study_first_posted>
  <last_update_submitted>October 5, 2021</last_update_submitted>
  <last_update_submitted_qc>October 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

